| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30055939 | HIV | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS30055940 | HIV | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS30055941 | HIV | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS20040704 | HPV | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS44043072 | HTLV-1 | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS44048213 | HTLV-1 | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
| TVIS44048233 | HTLV-1 | ENSG00000186951.17 | protein_coding | PPARA | No | No | 5465 | Q07869 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PPARA |
|---|---|
| DrugBank ID | DB04557 |
| Drug Name | Arachidonic Acid |
| Target ID | BE0000071 |
| UniProt ID | Q07869 |
| Regulation Type | |
| PubMed IDs | 10403814; 15491415 |
| Citations | Murakami K, Ide T, Suzuki M, Mochizuki T, Kadowaki T: Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochem Biophys Res Commun. 1999 Jul 14;260(3):609-13.@@Downie MM, Sanders DA, Maier LM, Stock DM, Kealey T: Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. Br J Dermatol. 2004 Oct;151(4):766-75. |
| Groups | Experimental |
| Direct Classification | Long-chain fatty acids |
| SMILES | CCCCCC=C/CC=C/CC=C/CC=C/CCCC(O)=O |
| Pathways | Arachidonic Acid Metabolism; Flurbiprofen Action Pathway; Rofecoxib Action Pathway; Ketoprofen Action Pathway; Sulindac Action Pathway; Fenoprofen Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; Tolmetin Action Pathway; Lornoxicam Action Pathway; Trisalicylate-Choline Action Pathway; Antrafenine Action Pathway; Celecoxib Action Pathway; Suprofen Action Pathway; Indomethacin Action Pathway; Valdecoxib Action Pathway; Ketorolac Action Pathway; Acetylsalicylic Acid Action Pathway; Antipyrine Action Pathway; Tiaprofenic Acid Action Pathway; Alpha Linolenic Acid and Linoleic Acid Metabolism; Ibuprofen Action Pathway; Tenoxicam Action Pathway; Salicylic Acid Action Pathway; Diclofenac Action Pathway; Nepafenac Action Pathway; Leukotriene C4 Synthesis Deficiency; Magnesium Salicylate Action Pathway; Diflunisal Action Pathway; Etodolac Action Pathway |
| PharmGKB | |
| ChEMBL | CHEMBL15594 |
